GL1X · GenesisL1 explorer

MolNFT v1 · #32213 · protein

High resolution structure of myo-inositol monophosphatase, the target of lithium therapy

2BJI · Inositol-1(OR 4)-monophosphatase: “High resolution structure of myo-inositol monophosphatase, the target of lithium therapy”. X-ray diffraction, 1 ligand (MG), 5 pockets (best druggability 0.77). MolNFT v1 #32213 on GenesisL1: 3D…

PDB
2BJI
Type
protein
Length
548 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Inositol-1(OR 4)-monophosphatase
EC
3.1.3.25
UniProt
P20456
Ligands
MG
Pockets
5 · best druggability 0.77

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BInositol-1(OR 4)-monophosphatase (EC 3.1.3.25)protein27438% helix, 24% strandP20456

Ligands and binding sites

  • MG · Magnesium ion · metal · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13670.770.8743MG
23430.750.8746MG
31120.740.9520empty
42350.490.7438empty
51440.430.7528empty

Interfaces

1 interface between chains.

  • A–B · 1594 Ų buried · 19 hydrogen bonds · protein-protein

Compared structures

  • 2BJI · High Resolution Structure of myo-Inositol Monophosphatase, The Target of Lithium Therapy · the same entry in another collection · chain A against A, TM-score 1.00
  • P20456 · AlphaFold monomer V2.0 prediction for inositol monophosphatase 1 (P20456) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.